chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hot flush, Lung disorder
Clinical narrative: No fever but chills; Hot flashes; Severe body aches; Sore throat; Heavy lungs; Headache; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 45-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 14Apr2021 at 17:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 at 17:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient also took previously paracetamol (TYLENOL) on an unknown date and experienced drug allergy. On 15Apr2021, the patient experienced no fever but chills, hot flashes, severe body aches, sore throat, heavy lungs, headache and extreme fatigue. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, hot flashes, severe body aches, sore throat, heavy lungs, headache and extreme fatigue were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain
Clinical narrative: No fever but chills; Hot flashes; Severe body aches; Sore throat; Heavy lungs; Headache; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 45-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 14Apr2021 at 17:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 at 17:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient also took previously paracetamol (TYLENOL) on an unknown date and experienced drug allergy. On 15Apr2021, the patient experienced no fever but chills, hot flashes, severe body aches, sore throat, heavy lungs, headache and extreme fatigue. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, hot flashes, severe body aches, sore throat, heavy lungs, headache and extreme fatigue were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Ew0171) via an unspecified route of administration in the left arm on 17Apr2021 at 08:45 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other vaccine within four weeks prior to the vaccination included first dose of tetanus vaccine toxoid/ diphtheria vaccine toxoid/ pertussis vaccine acellular (TDAP), Lot Number: 207377 on 09Mar2021 for immunisation. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) for an unknown indication from an unknown date and unknown if ongoing. On 18Apr2021 at 00:30, the patient experienced diarrhea. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event diarrhea was recovered on an unspecified date in Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Was extremely tired and just wanted to sleep for three days!; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8731) via an unspecified route of administration in the left arm on 14Apr2021 at 10:45 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took morphine (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via an unspecified route of administration in the left arm on 24Mar2021 at 10:45 (at the age of 63-year-old), as a single dose for COVID-19 immunisation. On 14Apr2021 at 20:00, the patient was extremely tired and just wanted to sleep for three days. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extremely tired was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Malaise, Nausea
Clinical narrative: Headache; Diarrhea; Nausea; Not feeling well; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 14Apr2021 at 11:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included back problems and breast cancer-remission. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient received unspecified medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 13:00, the patient experienced headache diarrhea nausea and not feeling well. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, diarrhea, nausea and not feeling well was not recovered at this time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Testicular pain
Clinical narrative: Extreme abdominal cramps; Moderate testicle pain; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0153) via an unspecified route of administration in the left arm on 16Apr2021 at 17:15 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included insomnia from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included trazodone (MANUFACTURER UNKNOWN) and zolpidem tartrate (AMBIEN) both for an unknown indication on an unknown dates and unknown if ongoing. The patient previously took cefalexin (KEFLEX) for an unknown indication on unknown date and experienced drug allergy. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732) via an unspecified route of administration in the left arm on 26Mar2021 at 17:15 as a single dose for COVID-19 immunisation. On 18Apr2021 at 09:00, the patient experienced extreme abdominal cramps and moderate testicle pain. The events did not result in doctor or other healthcare professional office or clinic, emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme abdominal cramps and moderate testicle pain were resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Cough, Dyspnoea, Pain
Clinical narrative: High Fever of 103; Extreme body aches and pains; Chills (was extremely cold); Cough; Unable to take a deep breath; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 16Apr2021 at 14:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, gastric bypass and vsg surgery (sleeve gastrectomy). The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included iron (MANUFACTURER UNKNOWN), cyanocobalamin (VITAMIN B-12), curcuma longa rhizome (TURMERIC) and vitamin d nos (MANUFACTURER UNKNOWN) and multi-vitamin (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 26Mar2021 at 14:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 08:00, the patient experienced high fever of 103(unspecified units), extreme body aches and pains, chills (was extremely cold), cough and unable to take a deep breath. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events high fever of 103 (unspecified units), extreme body aches and pains, chills (was extremely cold), cough and unable to take a deep breath was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: High Fever of 103; Extreme body aches and pains; Chills (was extremely cold); Cough; Unable to take a deep breath; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 16Apr2021 at 14:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, gastric bypass and vsg surgery (sleeve gastrectomy). The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included iron (MANUFACTURER UNKNOWN), cyanocobalamin (VITAMIN B-12), curcuma longa rhizome (TURMERIC) and vitamin d nos (MANUFACTURER UNKNOWN) and multi-vitamin (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 26Mar2021 at 14:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 08:00, the patient experienced high fever of 103(unspecified units), extreme body aches and pains, chills (was extremely cold), cough and unable to take a deep breath. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events high fever of 103 (unspecified units), extreme body aches and pains, chills (was extremely cold), cough and unable to take a deep breath was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Nausea
Clinical narrative: Chills; Nausea; Headache; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 15Apr2021 at 14:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy (sulfonamide allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. Concomitant medications included linaclotide (LINZESS) and blood pressure medications (MANUFACTURER UNKNOWN) for unknown indications from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 25Mar2021 at 14:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 14:00, the patient experienced chills, nausea, headache and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, nausea, headache and diarrhea was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Throat irritation, Vaccination site pain, Vaccination site swelling
Clinical narrative: she has injection site pain; she has injection site pain and swelling; little lump in axillary nodes region; she had irritated throat; This is a spontaneous report from a contactable consumer (patient) or other non-health care professional. A 49-year-old female patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 12Apr2021 as dose 1, single for covid-19 immunization. Medical history included asthma, she suffers asthma from an unknown date to ongoing. The patient's concomitant medications were not reported. On an unspecified date in 2021 the patient experienced she has injection site pain and swelling, little lump in axillary nodes region, she had irritated throat. Patient reported that she has not seen a physician and she was scheduled for a mammography test and she was afraid that the swollen lymph node could affect the results. The patient wanted to know how long the adverse effects will last after first dose administration of Pfizer's COVID-19 vaccine, requested information about whether Advil was an adequate medication for symptoms management caused by first dose administration of Pfizer's COVID-19 vaccine and requested information about whether the second dose of Pfizer's COVID-19 vaccine would be worse as to adverse effects. Treatment received with Advil for injection site pain and swelling, symptoms management. Outcome of the events were unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dizziness, Headache, Nausea
Clinical narrative: Body aches; Body chills; Nausea; 101 degree fever; Headache; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 18Apr2021 at 13:45 (at the age of 25-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, endometriosis, and asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), ethinylestradiol, norgestimate (SPRINTEC) and fexofenadine hydrochloride (ALLEGRA); all for unknown indication from unknown date, and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient underwent SARS-CoV-2 test (nasal swab) and the result was negative. On 19Apr2021 at 05:00, the patient experienced body aches, body chills, nausea, 101 degree fever, headache, and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 19Apr2021, the patient underwent body temperature test and the result was 101 (unspecified units). Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events body aches, body chills, nausea, 101 degree fever, headache, and dizziness were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: Body aches; Body chills; Nausea; 101 degree fever; Headache; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 18Apr2021 at 13:45 (at the age of 25-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, endometriosis, and asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), ethinylestradiol, norgestimate (SPRINTEC) and fexofenadine hydrochloride (ALLEGRA); all for unknown indication from unknown date, and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient underwent SARS-CoV-2 test (nasal swab) and the result was negative. On 19Apr2021 at 05:00, the patient experienced body aches, body chills, nausea, 101 degree fever, headache, and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 19Apr2021, the patient underwent body temperature test and the result was 101 (unspecified units). Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events body aches, body chills, nausea, 101 degree fever, headache, and dizziness were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Irritability, Pain in extremity, Pyrexia
Clinical narrative: Onset of feeling tired; Irritable; Headache; Fever (not documented with a thermometer); Achy arm; This is a spontaneous report from a contactable physician. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 16Apr2021 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included iodine contrast allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. It was unknown if the patient received any medication within two weeks of vaccination. On 16Apr2021, starting 3 hours after the second dose of the Pfizer COVID vaccine, the patient experienced the onset of feeling tired, irritable, headache, fever (not documented with a thermometer) and achy arm. All the events resolved within about 3 to 4 hours except for local arm ache which the patient felt was not unusual for a vaccine. The patient was the reporter's friend and she had called on 18Apr2021 and related the above, "so that you can report it". The reporting physician was not the patient's physician. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events feeling tired, irritable, headache, fever and achy arm were resolved on an unknown date in Apr2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Hypoaesthesia, Limb discomfort, Loss of personal independence in daily activities, Pain
Clinical narrative: I developed Numbness in right leg and heaviness; I developed Numbness in right leg and heaviness; I now have extreme squeaky and pain when walking; I now have extreme squeaky and pain when walking. I have not been able to daily activities and have had to get a cane to help me walk.; I have not been able to daily activities and have had to get a cane to help me walk.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 15Apr2021 at 13:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included sjogren's syndrome, fibromyalgia and hip replacement two years ago. Concomitant medications taken within two weeks of vaccination included duloxetine hydrochloride (CYMBALTA), gabapentin (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. The patient previously received tetanus vaccine (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 19:30, the patient developed numbness in right leg and heaviness. The patient had a hip replacement two years ago and no problems up till time of vaccine. The patient, on 15Apr2021 at 19:30, had extreme squeaky and pain when walking. She had not been able to do daily activities and had to get a cane to help her walk. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included medicine (unspecified). On an unknown date in Apr2021, the patient had an x-ray taken and the result was unknown. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events developed numbness in right leg and heaviness; had extreme squeaky and pain when walking; had not been able to do daily activities and has had to get a cane to help her walk was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: I developed Numbness in right leg and heaviness; I developed Numbness in right leg and heaviness; I now have extreme squeaky and pain when walking; I now have extreme squeaky and pain when walking. I have not been able to daily activities and have had to get a cane to help me walk.; I have not been able to daily activities and have had to get a cane to help me walk.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 15Apr2021 at 13:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included sjogren's syndrome, fibromyalgia and hip replacement two years ago. Concomitant medications taken within two weeks of vaccination included duloxetine hydrochloride (CYMBALTA), gabapentin (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. The patient previously received tetanus vaccine (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 19:30, the patient developed numbness in right leg and heaviness. The patient had a hip replacement two years ago and no problems up till time of vaccine. The patient, on 15Apr2021 at 19:30, had extreme squeaky and pain when walking. She had not been able to do daily activities and had to get a cane to help her walk. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included medicine (unspecified). On an unknown date in Apr2021, the patient had an x-ray taken and the result was unknown. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events developed numbness in right leg and heaviness; had extreme squeaky and pain when walking; had not been able to do daily activities and has had to get a cane to help her walk was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Around 6:00 am on April 18th, 2021, "my" body developed hives, on "my" arms, legs.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0151) via an unspecified route of administration in the left arm on 14Apr2021 at 14:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included may be allergy to penicillin and cephalosporin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other vaccine within four weeks prior to the vaccination included first dose of influenza vaccine, Lot number: unknown via an unspecified route of administration in the left arm on 09Mar2021 as a single dose for immunization. Concomitant medications included multivitamins (VITAPRIME) by labs for an unknown indication on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via an unspecified route of administration in the left arm on 23Mar2021 at 14:45 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. On 18Apr2021 at 06:00, 88 hours after receiving the second shot of vaccination, the patient body developed hives, on his arms and legs. On 19Apr2021, as writing this, he did not see hives anymore. The event did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. Therapeutic measures were taken as a result of the reported event and included treatment with fexofenadine hydrochloride (ALLEGRA) from an unspecified date in Apr2021 and unknown if ongoing. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event body developed hives, on arms and legs was resolved on 19Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Fatigue, Headache
Clinical narrative: Fatigue (1 week); Headaches (1 week); Diarrhea (2 days); Joint pain (2 weeks); This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CR8733) via an unspecified route of administration in the right arm on 29Mar2021 at 12:45 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. Medical history included bicuspid aortic valve, fatty liver, paroxysmal supraventricular tachycardia (paroxysmal SVT), anomalous right coronary artery and known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN) and fexofenadine hydrochloride (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date and unknown if ongoing. On 29Mar2021, the patient experienced fatigue (1 week), headaches (1 week), diarrhea (2 days) and joint pain (2 weeks). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event diarrhea (2 days) was recovered on 31Mar2021, after the duration of 2 days. The clinical outcome of the events fatigue (1 week) and headaches (1 week) was recovered on an unspecified date in Apr2021, after the duration of 1 week. The clinical outcome of the event joint pain (2 weeks) was recovered on an unspecified date in Apr2021, after the duration of 2 weeks.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Severe joint pain; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the arm left on 17Apr2021 at 15:00(at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included latex allergy and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 27Mar2021 at 15:00(at the age of 52-years-old) as a single dose for COVID-19 immunisation. On 18Apr2021 at 00:00, the patient experienced severe joint pain. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of severe joint pain and included treatment with ibuprofen (MANUFACTURER UNKNOWN) and liquids. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe joint pain was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Malaise, Thinking abnormal
Clinical narrative: Looser stools; Feel pretty lousy; Very fatigued; Headachy; Lack of mental clarity; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO158) via an unspecified route of administration in the left arm on 09Apr2021 at 14:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included sensitive as it was reported that the patient was not aware of any known allergies but was sensitive. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included natural progesterone (MANUFACTURER UNKNOWN), ergocalciferol (Vit d), ascorbic acid (Vit c) and other unspecified medications; all for unknown indications from unknown dates and unknown if ongoing. On 10Apr2021 at 17:00, the patient felt pretty lousy, very fatigued, headachy and lack of mental clarity. On 19Apr2021, just at the time of this report, the patient had looser stools. The events felt pretty lousy, very fatigued, headachy and lack of mental clarity were resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events feel pretty lousy, very fatigued, headachy, lack of mental clarity and looser stools was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Chills, Fatigue, Feeling abnormal
Clinical narrative: 1 week post vaccination felt chills; 1 week post vaccination felt brain fog; Headache above eyes; Body aches; Rapid heart rate; Blood pressure increased; Tiredness; Fatigue; Day post vaccination a sore and throbing LT arm; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150) via an unspecified route of administration in the left arm on 09Apr2021 at 09:30 (at the age of 69-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, vertigo, Central Nervous System hypersensitivity, inner ear vestibulopathy, anxiety, osteopenia and hypercholesteremia. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included atorvastatin calcium (LIPITOR), calcium carbonate (CALTRATE), vitamin d not otherwise specified (VITAMIN D), alendronate sodium (FOSAMAX), ascorbic acid (VITAMIN C) and beclometasone dipropionate (QVAR); all taken for unknown indication from an unknown dates and unknown if ongoing. On 10Apr2021, a day post vaccination, the patient experienced sore and throbbing left arm. On 16Apr2021 at 22:30, 1 week post vaccination, the patient felt chills, brain fog, headache above eyes, body aches, rapid heart rate, increased blood pressure readings, tiredness and fatigue. These symptoms were lasting for 3 days and on 19apr2021 the patient felt somewhat improved although was feeling fatigued. On 16Apr2021 at 22:30, the patient underwent lab tests and procedures which included heart rate and blood pressure and the result was found to be rapid for heart rate and increased for blood pressure. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. No therapeutic measures were taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore, throbbing left arm, felt chills, brain fog, headache above eyes, body aches, rapid heart rate, increased blood pressure readings and tiredness were recovering, while the event fatigue was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate, Heart rate increased, Pain, Pain in extremity
Clinical narrative: 1 week post vaccination felt chills; 1 week post vaccination felt brain fog; Headache above eyes; Body aches; Rapid heart rate; Blood pressure increased; Tiredness; Fatigue; Day post vaccination a sore and throbing LT arm; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150) via an unspecified route of administration in the left arm on 09Apr2021 at 09:30 (at the age of 69-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, vertigo, Central Nervous System hypersensitivity, inner ear vestibulopathy, anxiety, osteopenia and hypercholesteremia. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included atorvastatin calcium (LIPITOR), calcium carbonate (CALTRATE), vitamin d not otherwise specified (VITAMIN D), alendronate sodium (FOSAMAX), ascorbic acid (VITAMIN C) and beclometasone dipropionate (QVAR); all taken for unknown indication from an unknown dates and unknown if ongoing. On 10Apr2021, a day post vaccination, the patient experienced sore and throbbing left arm. On 16Apr2021 at 22:30, 1 week post vaccination, the patient felt chills, brain fog, headache above eyes, body aches, rapid heart rate, increased blood pressure readings, tiredness and fatigue. These symptoms were lasting for 3 days and on 19apr2021 the patient felt somewhat improved although was feeling fatigued. On 16Apr2021 at 22:30, the patient underwent lab tests and procedures which included heart rate and blood pressure and the result was found to be rapid for heart rate and increased for blood pressure. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. No therapeutic measures were taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore, throbbing left arm, felt chills, brain fog, headache above eyes, body aches, rapid heart rate, increased blood pressure readings and tiredness were recovering, while the event fatigue was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: PNC13
Symptoms: Oral mucosal blistering, Pain in extremity, Peripheral swelling, Skin warm
Clinical narrative: soreness of the arm; swelling and heating on the arm; swelling and heating on the arm; small blisters on her mouth; This is a spontaneous report from a contactable physician received via Pfizer-sponsored program. An 89-year-old female patient (reporter's mother) received pneumococcal 13-valent conjugate vaccine (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a SINGLE DOSE for immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient received Prevnar vaccine about 8 years ago and 8 days after receiving the Prevnar vaccine, she experienced soreness of the arm, swelling and heating on the arm and small blisters on her mouth. The outcome of the events was unknown.   No follow-up attempts are needed. No further information is expected. Information about batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache
Clinical narrative: chills; fatigue; joint pain; headaches; This is a spontaneous report from a contactable consumer or other non-health care professional received from Pfizer-sponsored program.    A female patient of an unspecified age received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), dose 1, single via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced chills, fatigue, joint pain (arthralgia) and headaches on an unspecified date. The caller called on behalf of her mother asking if she could take any medications for her symptoms or that would affect the vaccine. At the time of reporting, the outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: PPV
Symptoms: Hypersensitivity
Clinical narrative: allergic reaction to it; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received pneumococcal 13-valent conjugate vaccine (dipht crm197 protein), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced allergic reaction to it on an unspecified date. The outcome of the event was unknown.   Pfizer is a marketing authorization holder of [Pneumococcal 13-Val Conj Vac (Dipht CRM197 Protein] in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of [Pneumococcal 13-Val Conj Vac (Dipht CRM197 Protein] has submitted the same report to the regulatory authorities.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea, Rhinorrhoea, Sneezing
Clinical narrative: Short of breath; Sneezing; Sneezing /a lot of mucus; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, solution for injection, Lot number was not reported), dose number unknown via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. The patient medical history and concomitant medication was not reported. After 11 days of receiving the Pfizer vaccine on an unspecified date the patient experienced short of breath, sneezing continuously, and a lot of mucus only when patient only consumed ice cream, and this was repeated more than once, and it did not happen before. The clinical outcome of the events was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed, Muscle spasms, Nausea
Clinical narrative: Delayed menstrual; More than usual cramping; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration on an unknown date (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient medical history reported was not applicable. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. On an unknown date, the patient experienced delayed menstrual, more than usual cramping with nausea. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not tested for COVID-19. The clinical outcome of the events delayed menstrual, more than usual cramping with nausea was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Menstruation delayed
Clinical narrative: Delayed period; Lots of abdominal cramping; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021(at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. On 10Apr2021, the patient experienced delayed period and lots of abdominal cramping. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of events delayed period and lots of abdominal cramping was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.